My hon. Friend is surely making the case for the database because successes and failures would have to be recorded. She would therefore be able to benchmark and see the evidence behind such a claim. A company cannot choose just to record successes on the database.
Access to Medical Treatments (Innovation) Bill
Proceeding contribution from
Chris Heaton-Harris
(Conservative)
in the House of Commons on Friday, 16 October 2015.
It occurred during Debate on bills on Access to Medical Treatments (Innovation) Bill.
About this proceeding contribution
Reference
600 c567 Session
2015-16Chamber / Committee
House of Commons chamberLibrarians' tools
Timestamp
2021-11-04 13:31:28 +0000
URI
http://hansard.intranet.data.parliament.uk/Commons/2015-10-16/15101634000136
In Indexing
http://indexing.parliament.uk/Content/Edit/1?uri=http://hansard.intranet.data.parliament.uk/Commons/2015-10-16/15101634000136
In Solr
https://search.parliament.uk/claw/solr/?id=http://hansard.intranet.data.parliament.uk/Commons/2015-10-16/15101634000136